These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 895373)

  • 1. Differential effect of psychotropic drugs on dihydroxyphenylacetic acid (DOPAC) in the rat substantia nigra and caudate nucleus.
    Fadda F; Argiolas A; Stefanini E; Gessa GL
    Life Sci; 1977 Aug; 21(3):411-7. PubMed ID: 895373
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of psychotropic drugs on 3,4-dihydroxyphenylacetic acid (DOPAC) content in the medial basal hypothalamus.
    Argiolas A; Paglietti E; Fadda F; Quarantotti BP; Gessa GL
    Life Sci; 1978 Feb; 22(6):461-6. PubMed ID: 625191
    [No Abstract]   [Full Text] [Related]  

  • 3. Haloperidol increases DOPAC in the substantia nigra but not in the ventral tegmental area.
    Argiolas A; Fadda F; Melis MR; Gessa GL
    Life Sci; 1979 Jun; 24(24):2279-84. PubMed ID: 502748
    [No Abstract]   [Full Text] [Related]  

  • 4. Chronic haloperidol causes persistent increase in 3,4-dihydroxyphenylacetic acid (DOPAC) concentration in the substantia nigra but not in the ventral tegmental area.
    Argiolas A; Fadda F; Melis MR; Serra G; Gessa GL
    Brain Res; 1979 Oct; 175(1):178-82. PubMed ID: 487148
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of dopamine agonists and antagonists on DOPA formation in the substantia nigra.
    Argiolas A; Melis MR; Fadda F; Serra G; Gessa GL
    J Neurochem; 1982 Jan; 38(1):75-9. PubMed ID: 6809898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for a direct action of amphetamine on dopamine metabolism in the rat substantia nigra in vivo.
    Argiolas A; Fadda F; Stefanini E; Gessa GL
    Naunyn Schmiedebergs Arch Pharmacol; 1978; 301(3):171-4. PubMed ID: 634376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of effects of drugs on dopamine metabolism in the substantia nigra and the corpus striatum of rat brain.
    Westerink BH; Korf J
    Eur J Pharmacol; 1976 Nov; 40(1):131-6. PubMed ID: 991922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of intranigral administration of dopamine agonists and antagonists and baclofen on concentrations of dopac and dopamine in the striatum and substantia nigra of the rat.
    Wuerthele SM; Friedle NM; Moore KE
    J Neural Transm; 1979; 45(2):117-27. PubMed ID: 469523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of acute and chronic haloperidol treatment on striatal and nigral 3,4-dihydroxyphenylacetic acid (DOPAC) levels.
    Meller E; Friedhoff AJ; Friedman E
    Life Sci; 1980 Feb; 26(7):541-7. PubMed ID: 7366335
    [No Abstract]   [Full Text] [Related]  

  • 10. Differential effect of reserpine on dopaminergic receptor function in rat substantia nigra and caudate nucleus.
    Tonon G; Saiani L; Spano PF; Trabucchi M
    Brain Res; 1979 Jan; 160(3):553-8. PubMed ID: 217486
    [No Abstract]   [Full Text] [Related]  

  • 11. Changes in dopamine and DOPAC following systemic administration of apomorphine and 3,4-dihydroxyphenylamino-2-imidazoline (DPI) in rats.
    Springer J; Hannigan JH; Isaacson RL
    Brain Res; 1981 Sep; 220(1):226-30. PubMed ID: 7272755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effect of haloperidol on DOPAC levels in the substantia nigra and ventral tegmental area.
    Argiolas A; Fadda F; Melis MR; Gessa GL
    Pharmacol Res Commun; 1980 Jul; 12(7):683-8. PubMed ID: 7403237
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute and subacute effects of haloperidol on dopac levels in the substantia nigra and ventral tegmental area of rat brain.
    Scatton B
    Eur J Pharmacol; 1979 Jun; 56(1-2):183-4. PubMed ID: 467510
    [No Abstract]   [Full Text] [Related]  

  • 14. Release of dopamine in the ventral tegmental area of rat.
    Fadda F; Melis MR; Argiolas A; Perra G
    Boll Soc Ital Biol Sper; 1979 Jul; 55(12):1178-83. PubMed ID: 553533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3-Methoxytyramine formation following monoamine oxidase inhibition is a poor index of dendritic dopamine release in the substantia nigra.
    Elverfors A; Pileblad E; Lagerkvist S; Bergquist F; Jonason J; Nissbrandt H
    J Neurochem; 1997 Oct; 69(4):1684-92. PubMed ID: 9326297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental change in striatal concentration of homovanillic acid and 3,4-dihydroxyphenylacetic acid in response to apomorphine and haloperidol treatment.
    Nomura Y; Komori T; Okuda S; Segawa T
    Arch Int Pharmacodyn Ther; 1979 Jan; 237(1):25-30. PubMed ID: 485682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine, noradrenaline and 3,4-dihydroxyphenylacetic acid (DOPAC) levels of individual brain nuclei, effects of haloperidol and pargyline.
    Fekete MI; Herman JP; Kanyicska B; Palkovits M
    J Neural Transm; 1979; 45(3):207-18. PubMed ID: 479873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effect of acute and chronic ethanol on dopamine metabolism in frontal cortex, caudate nucleus and substantia nigra.
    Fadda F; Argiolas A; Melis MR; Serra G; Gessa GL
    Life Sci; 1980 Sep; 27(11):979-86. PubMed ID: 7432099
    [No Abstract]   [Full Text] [Related]  

  • 19. Apomorphine- and haloperidol-induced change in 3,4-dihydroxyphenylacetic acid content in the mesolimbic-striatum of the developing rat.
    Nomura Y; Oki K; Segawa T
    J Pharmacobiodyn; 1980 Feb; 3(2):111-6. PubMed ID: 7205536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Injections of 6-hydroxydopamine in the substantia nigra of the rat brain: morphological and biochemical effects.
    Buonamici M; Cervini MA; Rossi AC; Sebastiani L; Raffaelli A; Bagnoli P
    Behav Brain Res; 1990 Apr; 38(1):83-95. PubMed ID: 2112003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.